Abstract:BACKGROUND: Paclitaxel (PTX) is a first-line chemotherapeutic drug for the treatment of prostate cancer. However, most patients develop resistance and metastasis, and thus new therapeutic approaches are urgently required. Recent studies have identified widespread anti-tumor effects of zinc (Zn) in various tumor cell lines, especially prostate cancer cells. In this study, we examined the effects of Zn as an adjuvant to PTX in prostate cancer cells.METHODS: PC3 and DU145 cells were treated with different concentrations of Zn and/or PTX. MTT assay was used to detect cell viability. Real-time cell analysis (RTCA) and microscopy were used to observe morphological changes in cells. Western blotting was used to detect the expression of epithelial-mesenchymal transition (EMT)-related proteins. qPCR (reverse transcription-polymerase chain reaction) was used to examine changes in TWIST1 mRNA levels. Cell invasion and migration were detected by scratch and transwell assays. shRNA against TWIST1 was used to knockdown TWIST1. Colony formation assay was used to detect cell proliferation, while Annexin V and propidium iodide (PI) staining was used to detect cell apoptosis.RESULTS: Zn and PTX increased proliferation inhibition in a dose- and time-dependent manner in prostate cancer cells, while Zn increased prostate cancer cell chemosensitivity to PTX. Combined Zn and PTX inhibited prostate cancer cell invasion and migration by downregulating the expression of TWIST1. Furthermore, knockdown of TWIST1 increased the sensitivity of prostate cancer cells to PTX. In addition, Zn and PTX reduced cell proliferation and induced apoptosis in prostate cancer cells.CONCLUSIONS: Our results demonstrated that Zn and PTX combined therapy inhibits EMT by reducing the expression of TWIST1, which reduces the invasion and migration of prostate cancer cells. SiTWIST1 increased the sensitivity of prostate cancer cells to PTX. In addition, with prolonged treatment, Zn and PTX inhibited proliferation and led to prostate cancer cell apoptosis. Therefore, Zn may be a potential adjuvant of PTX in treating prostate cancer and combined treatment may offer a promising therapeutic strategy for prostate cancer.

Zinc induces a bell-shaped proliferative dose-response effect in cultured smooth muscle cells from benign prostatic hyperplasia

Effect Of Zinc On Prostatic Tumorigenicity In Nude Mice

Effect of Zinc on Human Prostatic Carcinoma Cell Growth

Long-term zinc treatment alters the mechanical properties and metabolism of prostate cancer cells

Effects of Exogenous Zinc on Cell Cycle, Apoptosis and Viability of MDAMB231, HepG2 and 293 T Cells

Down regulation by a low-zinc diet in gene expression of rat prostatic thymidylate synthase and thymidine kinase

Endogenous Zinc-Ion-Triggered in Situ Gelation Enables Zn Capture to Reprogram Benign Hyperplastic Prostate Microenvironment and Shrink Prostate.

Advances of Zinc Signaling Studies in Prostate Cancer

Effects of E/Z Isomers of Lycopene on Experimental Prostatic Hyperplasia in Mice

Effects of E/Z isomers of lycopene on experimental prostatic hyperplasia in mice.

The Effect of Chronic Prostatitis on Zinc Concentration of Prostatic Fluid and Seminal Plasma: a Systematic Review and Meta-Analysis

Effects Of Exogenous Zinc On The Cellular Zinc Distribution And Cell Cycle Of A549 Cells

A Systematic Review of the Zinc Content of the Normal Human Prostate Gland

Human-like hyperplastic prostate with low ZIP1 induced solely by Zn deficiency in rats

Zinc promotes prostate cancer cell chemosensitivity to paclitaxel by inhibiting epithelial‐mesenchymal transition and inducing apoptosis

Zhuangyao Jianshen pill ameliorates testosterone-induced benign postatic hyperplasia in rats

Zinc Promotes Cell Proliferation Via Regulating Metal-Regulatory Transcription Factor 1 Expression and Transcriptional Activity in Pulmonary Arterial Hypertension.

Zinc abates sodium benzoate -induced testicular dysfunction via upregulation of Nrf2/ HO-1/ Nf-κB signaling and androgen receptor gene

Endogenous Zinc Ion‐Triggered In‐Situ Gelation Enables Zn Capture to Reprogramme Benign Hyperplastic Prostate Microenvironment and Shrink Prostate

[Clinical Study of Zinc for the Treatment of Chronic Bacterial Prostatitis].

S100A4 modulates cell proliferation, apoptosis and fibrosis in the hyperplastic prostate